Anticoagulation in atrial fibrillation and end-stage kidney disease on hemodialysis: a meta-analysis of randomized trials comparing direct oral anticoagulants with vitamin K antagonists
CONCLUSION: Orally administered activated factor X inhibitors carried a similar risk of bleeding and death when compared with VKAs in patients with NVAF undergoing chronic hemodialysis. Moreover, there was a trend towards a reduction of thromboembolic events or stroke in patients receiving DOACs.PMID:38404942 | PMC:PMC10885786 | DOI:10.1016/j.rpth.2024.102332
Source: Thrombosis and Haemostasis - Category: Hematology Authors: Maximilian Tscharre Daniel Steiner David Mutschlechner Cihan Ay Thomas Gremmel Source Type: research
More News: Atrial Fibrillation | Bleeding | Dialysis | Hematology | Hemodialysis | Science | Stroke | Study | Thrombosis | Urology & Nephrology | Vitamin K | Vitamins